Biosenic (CHIX:BIOSB) Moat Score: 0/10 (As of Jul. 02, 2026)


CHIX:BIOSB Biosenic CHIX:BIOSB
9 GF Score
Price €2.60
View Full Analysis

What is Biosenic Moat Score?

Biosenic has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Biosenic has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Biosenic might have No Moat - No discernible moat.

Biosenic  (CHIX:BIOSb) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Biosenic Moat Score Related Terms

CHIX:BIOSB
9GF Score
Biosenic CHIX:BIOSB
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biosenic Business Description

Address Rue Granbonpre 11, Batiment H (bte 24), Mont-St-Guibert, BEL, 1435
Biosenic is engaged in the development of cell therapy products for orthopaedics and bone diseases. The product pipeline of the company includes; ALLOB for treatment of delayed-union fractures, spinal fusion procedures and revision spinal fusion, and PREOB. In addition, the firm is also focused on conducting preclinical research on next-generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications.
9GF Score

Get the complete analysis for CHIX:BIOSB

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.60
Price